Vertical Transmission of Hepatitis C Virus

NCT02044042 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2015-10-02

No results posted yet for this study

Summary

Vertical HCV Transmission has been extensively studied, with a risk around 5% (range: 3 to 10%). Spontaneous viral clearance in infected children during childhood can occur, but data about this phenomenon are scarse, justifying the study.

Conditions

  • Hepatitis C
  • Transmission

Sponsors & Collaborators

  • Hopital Lariboisière

    lead OTHER

Principal Investigators

  • Pierre O SELLIER, M.D., Ph.D · Hopital Lariboisiere

Eligibility

Min Age
9 Months
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02044042 on ClinicalTrials.gov